Board

Board

Arie Cohen

Executive Chair of the Board
Mr. Cohen has over thirty years of experience as a senior executive in the medical technology industry, compiling a successful track record in growing young companies and corporate operating divisions. Mr. Cohen is an Operating Executive with SFW Capital Partners, a private equity firm, since 2009. Previously, he was the President and Chief Executive Officer at CardioNet, a leading wireless medical technology company with focus on remote diagnosis and monitoring of cardiac arrhythmias. Mr. Cohen led CardioNet to successful IPO and Secondary Offering in 2008. Before joining CardioNet, Mr. Cohen was the Group President at Viasys Healthcare. He led the $450 million Respiratory Care Group overseeing 1200 employees in various locations around the globe. Viasys Healthcare was acquired in 2007 by Cardinal Health for $1.5 billion. Previously, he held executive positions with Respironics, Datascope and Air-Shields. Mr. Cohen has a B.S. in Electrical Engineering and M.S. in Biomedical Engineering from University of California, Los Angeles.

 
Prof. Banu Onaral
Board Member
Dr. Onaral is H. H. Sun Professor of Biomedical Engineering and Electrical Engineering at Drexel University. She holds a Ph.D. in Biomedical Engineering from the University of Pennsylvania and BSEE and MSEE in Electrical Engineering from Bogazici University, Istanbul, Turkey. Dr. Onaral joined the faculty of the Electrical and Computer Engineering Department and the Biomedical Engineering and Science Institute in 1981. She has served as the founding Director of the School of Biomedical Engineering Science and Health Systems since 1997. Dr. Onaral’s academic focus both in research and teaching is centered on signals and systems engineering with special emphasis on biomedical signal processing. She has led major research and development projects sponsored by the National Science Foundation (NSF), National Institutes of Health (NIH), Office of Naval Research (ONR), DARPA and Department of Homeland Security (DHS). She supervised many graduate students and has an extensive publication record in biomedical signals and systems. She is the recipient of a number of faculty excellence awards including the 1990 Lindback Distinguished Teaching Award of Drexel University, the EDUCOM Best educational Software award and the NSF Faculty Achievement Award. Dr. Onaral’s professional services include chair and membership on advisory boards and strategic planning bodies of several universities and funding agencies, including service on the National Science Foundation’s Engineering Advisory Board, and on the proposal review panels and study sections. Her editorial responsibilities have included service on the Editorial Board of journals and the CRC Biomedical Engineering Handbook as Section Editor for Biomedical Signal Analysis. She served as the President of the IEEE Engineering in Medicine and Biology Society (EMBS), the largest member-based biomedical engineering society in the world. Earlier she had organized and chaired the 1990 Annual International Conference of the EMBS. She is currently serving as the Co-Chair of the 2004 Annual Conference of the Biomedical Engineering society. She has been a member of the inaugural Board of the American Institute for Medical and Biological Engineering. She is a Founding Fellow of the American Institute for Medical and Biological Engineering, a Fellow of the IEEE and the AAAS.

 
Peter Chance
Board Member
Mr. Chance is President of Non-Invasive Technology, Inc., a private company which licenses fundamental patents to the diagnostic, non-invasive medical device area. Previously, using his background in Artificial Intelligence, he began work at Unimation, at the time the nation’s largest and oldest industrial robot manufacturer. Mr. Chance left Unimation with Mr. Weiss, an MIT graduate, to start their own robot manufacturing company, U.S. Robots. After producing its first and second generation assembly robots, the Maker 100 and 200 series, they sold the company to Square D Company, an electrical equipment manufacturer. Mr. Chance is a proponent of technology, innovation, and change, with a particular interest in the potential of Artificial Intelligence on the future. Mr. Chance belongs to a five generation Penn family, as the son of Dr. Britton Chance, an internationally known scholar and Professor Emeritus in Biochemistry/Biophysics, and nephew of Henry Chance II, a Penn Trustee and President of United Engineers, a family business founded by his grandfather, Edwin M. Chance, a graduate in Civil Engineering at Penn.

 
Shahram Hejazi, PhD
Board Member
Dr. Shahram Hejazi is a medical device/life science executive with general management experience in both early-stage ventures and large global companies. As a Venture Partner with BioAdvance, he is responsible for investments in device, diagnostics and imaging field. Within the BioAdvance portfolio, Dr. Hejazi focuses on working with mid/late stage molecular imaging, life science tools and diagnostics companies. He represents BioAdvance on the boards of Leversense LLC, Eagle Vision Pharmaceuticals Inc. and InfraScan, Inc. as well as serving as an Advisor to Optofluidics, Inc.

Previously, Dr. Hejazi was the President of Kodak’s life science division (now called Carestream Molecular Imaging), where he had global responsibility for R&D, manufacturing, operations, sales, marketing and service. While holding this position, Dr. Hejazi led the system business to successful double-digit annual growth and directed the launch of a new imaging agent business. Before Kodak, he was the CEO of Zargis Medical Corporation (an early stage medical device company that spun-off from Siemens), where he led the company’s efforts in areas ranging from raising capital and technology development to completion of several clinical trials, FDA approval and product launch. Prior to Zargis, Dr. Hejazi was the Head of the Strategic Business Development group at Siemens, responsible for identifying early-stage growth/investment opportunities and new business development in the medical field.

Dr. Hejazi has a Ph.D. in engineering with emphasis in biophysics and an executive business education at Stanford University.

 
Baruch Ben Dor
Chief Executive Officer and Board Member
Dr. Ben Dor is a Physics Ph.D. and a graduate of the highly prestigious “Talpiot” academy of the Israeli Air Force with experience in the Electro Optics field since 1988, both in the defense and in the medical device industries. In his recent job, Dr. Ben Dor was the general manager of a startup company (Medibell Medical Vision Technologies Ltd.) in the field of ophthalmic digital photography leading it through finishing of prototype R&D, beta testing, production setup and sales and marketing network development. Prior to Medibell Dr. Ben Dor served for a short period as the director of marketing in Medibell’s mother company, CMT Medical (OEM producer of digital X-ray for Toshiba Medical). Dr. Ben Dor gained his international marketing experience as the vascular program director in the marketing department of ESC/Sharplan, an Israeli based worldwide leader company in the field of medical lasers, building worldwide net of reference sites for sales support, conducting clinical studies and producing successful marketing campaigns.

 
Jennifer Hartt
Board Observer

Jennifer Hartt is Director of Investments, Life Sciences, for Ben Franklin Technology Partners of Southeastern Pennsylvania.

Hartt directs all of Ben Franklin’s life sciences investments in companies with technologies ranging from medical devices and diagnostics to therapeutics. Hartt has invested in over thirty companies for Ben Franklin since arriving in 2005. Hartt holds a Bachelor’s degree, graduating summa cum laude and Phi Beta Kappa, as well as a Master’s in Biology, both from the University of Pennsylvania. She has prior experience in lab research, clinical settings, business consulting for small and large companies, technology evaluation, licensing and equity management. Prior to joining Ben Franklin, Hartt was Associate Director of Business Development & Equity at the University of Pennsylvania. Hartt is involved in regional activities in technology development education and commercialization programs such as in being on a science curriculum audit committee, evaluating business plans, judging entrants in the Eastern Technology Council Enterprise Awards, mentoring students and representing her organization on the oversight committee for Coulter funding of translational research at Drexel University.

 

Tony Simonetta
Board Observer
Tony is currently Senior Vice President of Operations for the Philadelphia Industrial Development Corporation where he oversees all of PIDC’s support functions including finance, accounting, legal, IT, risk management, human resources, loan administration and contract administration.

His other professional experiences have included Special Assistant to the President – CEO of Temple University Health System where he provided leadership and oversight on a variety of complex financial, organizational and special projects; Chief Financial Officer, Treasurer and Corporate Secretary of a leading provider of biotechnology-based products and services for a broad range of life science, biotechnology, diagnostic and food safety applications, where he was responsible for the company’s finance, accounting, contract administration, investment management, human resources, risk management, IT and investor relations; and, he was a partner with KPMG LLP where he provided audit, accounting and consulting services to hundreds of companies as diverse as startups and the Fortune 100.

 

Stephen M. Goodman
Board Advisor
Stephen M. Goodman is a partner in Morgan Lewis’s Business and Finance Practice and has been with the firm since 1994. His practice, focused on corporate finance and acquisitions, is dedicated to fostering emerging growth companies in the Philadelphia region through direct work with clients and active involvement in the emerging growth community. As strategic counsel to startups in the technology and life sciences sectors, Mr. Goodman identifies companies with potential and takes them from conception through product development, growth, and beyond.

Mr. Goodman is a founder of and senior partner in the firm’s Emerging Business and Technology Practice. He has been consistently recognized by Chambers USA, an annual independent ranking of top lawyers, as an influential authority for his work with emerging growth companies. In May 2011, he received the Legend Award for Lifetime Achievement from the Greater Philadelphia Alliance for Capital and Technologies (PACT). In selecting Mr. Goodman for the honor, PACT noted, “He has played a leading role in nurturing scores of prominent success stories and is considered a valuable asset to the Greater Philadelphia business community.”

Mr. Goodman is also founder of the firm’s “Connect at Morgan Lewis” program, which brings together investors and entrepreneurs and guides clients through the process of refining their investor presentations through individual coaching sessions. He is the longest-tenured member of the advisory board for the University of Pennsylvania’s Wharton Entrepreneurial Program. He also teaches “Legal Aspects of Entrepreneurship” at the University of Pennsylvania’s School of Law. In addition to his close involvement with clients and his support and participation in the regional entrepreneurial and venture capital networks, Mr. Goodman devotes significant time to mentoring young lawyers in the firm.

Mr. Goodman earned his LL.B. from University of Pennsylvania Law School in 1965.